These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28277277)

  • 1. Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer.
    Chevalier MF; Bohner P; Pieraerts C; Lhermitte B; Gourmaud J; Nobile A; Rotman S; Cesson V; Martin V; Legris AS; Dartiguenave F; Gharbi D; De Leval L; Speiser DE; Nardelli-Haefliger D; Jichlinski P; Derré L
    Eur Urol; 2017 Jun; 71(6):854-857. PubMed ID: 28277277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells.
    Carenza C; Calcaterra F; Oriolo F; Di Vito C; Ubezio M; Della Porta MG; Mavilio D; Della Bella S
    Front Immunol; 2019; 10():1325. PubMed ID: 31244860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BTLA-Expressing Dendritic Cells in Patients With Tuberculosis Exhibit Reduced Production of IL-12/IFN-α and Increased Production of IL-4 and TGF-β, Favoring Th2 and Foxp3
    Zhang JA; Lu YB; Wang WD; Liu GB; Chen C; Shen L; Luo HL; Xu H; Peng Y; Luo H; Huang GX; Wu DD; Zheng BY; Yi LL; Chen ZW; Xu JF
    Front Immunol; 2020; 11():518. PubMed ID: 32296431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.
    Yang M; Yu Q; Liu J; Fu W; Cao Y; Yu L; Shao S; Wang X; Niu H; Wang Y
    J Surg Oncol; 2015 Sep; 112(4):430-5. PubMed ID: 26265374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.
    Fourcade J; Sun Z; Pagliano O; Guillaume P; Luescher IF; Sander C; Kirkwood JM; Olive D; Kuchroo V; Zarour HM
    Cancer Res; 2012 Feb; 72(4):887-96. PubMed ID: 22205715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not All Immune Checkpoints Are Created Equal.
    De Sousa Linhares A; Leitner J; Grabmeier-Pfistershammer K; Steinberger P
    Front Immunol; 2018; 9():1909. PubMed ID: 30233564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Src Suppresses Dendritic Cell Antitumor Activity via T Cell Ig and Mucin Protein-3 Receptor.
    Gujar R; Maurya N; Yadav V; Gupta M; Arora S; Khatri N; Sen P
    J Immunol; 2016 Sep; 197(5):1650-62. PubMed ID: 27439518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes.
    Kamal AM; Wasfey EF; Elghamry WR; Sabry OM; Elghobary HA; Radwan SM
    Clin Biochem; 2021 Oct; 96():13-18. PubMed ID: 34217699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania donovani Impedes Antileishmanial Immunity by Suppressing Dendritic Cells via the TIM-3 Receptor.
    Akhtar MN; Kumar S; Sen P
    mBio; 2022 Aug; 13(4):e0330921. PubMed ID: 35924848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous transduction of dendritic cells with A20 and BTLA genes stimulates the development of stable and efficient tolerogenic dendritic cells and induces regulatory T cells.
    Javan MR; Rahimpour A; Moazzeni SM
    Int Immunopharmacol; 2021 Oct; 99():107966. PubMed ID: 34315113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the immunological markers BTLA, TIM-3, and PD-L1 at the invasion front and tumor center in clear cell renal cell carcinoma.
    Stühler V; Alemi B; Rausch S; Stenzl A; Schwab M; Schaeffeler E; Bedke J
    World J Urol; 2024 Jan; 42(1):53. PubMed ID: 38244072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulation of dendritic cells by the receptor T cell Ig and mucin protein-3 via Bruton's tyrosine kinase and c-Src.
    Maurya N; Gujar R; Gupta M; Yadav V; Verma S; Sen P
    J Immunol; 2014 Oct; 193(7):3417-25. PubMed ID: 25172495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells.
    Jones A; Bourque J; Kuehm L; Opejin A; Teague RM; Gross C; Hawiger D
    Immunity; 2016 Nov; 45(5):1066-1077. PubMed ID: 27793593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockade.
    Grabmeier-Pfistershammer K; Stecher C; Zettl M; Rosskopf S; Rieger A; Zlabinger GJ; Steinberger P
    Clin Immunol; 2017 Oct; 183():167-173. PubMed ID: 28882621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory Checkpoint Receptor TIM-3 as a Regulator of the Functional Activity of Dendritic Cells.
    Tyrinova TV; Chernykh ER
    Bull Exp Biol Med; 2024 Jul; 177(3):287-292. PubMed ID: 39123087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new development of FG-CC' siRNA blocking interaction of Tim-1 and Tim-4 can enhance DC vaccine against gastric cancer .
    Sun HW; Wu C; Tan HY; Wang QS
    Hepatogastroenterology; 2012; 59(120):2677-82. PubMed ID: 22709877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute aerobic exercise induces a preferential mobilisation of plasmacytoid dendritic cells into the peripheral blood in man.
    Brown FF; Campbell JP; Wadley AJ; Fisher JP; Aldred S; Turner JE
    Physiol Behav; 2018 Oct; 194():191-198. PubMed ID: 29763678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells.
    Carrascal MA; Severino PF; Guadalupe Cabral M; Silva M; Ferreira JA; Calais F; Quinto H; Pen C; Ligeiro D; Santos LL; Dall'Olio F; Videira PA
    Mol Oncol; 2014 May; 8(3):753-65. PubMed ID: 24656965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased B and T lymphocyte attenuator in Behcet's disease may trigger abnormal Th17 and Th1 immune responses.
    Ye Z; Deng B; Wang C; Zhang D; Kijlstra A; Yang P
    Sci Rep; 2016 Feb; 6():20401. PubMed ID: 26841832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.